Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Prospective Evaluation of Outcomes of Radiosurgical Treatment of Early Stage Non-Small Cell Lung Cancer (NSCLC)

NCT00643318 is registered in ClinicalTrials.gov with Accuray Incorporated as lead sponsor.

NCT NCT00643318
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00643318 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Prospective Evaluation of Outcomes of Radiosurgical Treatment of Early Stage Non-Small Cell Lung Cancer (NSCLC)
Lead sponsor
Accuray Incorporated
Phase
Phase 2
Overall status
Unknown status
Start date
April 30, 2006
Completion date
December 31, 2021
Enrollment
40 (actual)
Sites
23

Conditions

As the registry lists them; a condition with its own page is linked.

non-small cell lung cancer